1-4 of 4
Ping Chen, MD PhD
Close
Sort by
Journal Articles

Telomerase Inhibition Impairs Self-Renewal of ß-Catenin Activated Myeloproliferative Neoplasm Progenitors

Wenxue Ma, MD PhD, Cayla Mason, BS, Ping Chen, MD PhD, Qingfei Jiang, PhD, Nathan Delos Santos, BS, Elisa Lazzari, PhD, Sheldon Morris, MD MPH, Phoebe Mondala, BS, Jane Isquith, BS, MS, Fei Huang, PhD, Larissa Balaian, PhD, Catriona Jamieson, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2860.
https://doi.org/10.1182/blood.V130.Suppl_1.2860.2860
Published: 2017
Journal Articles

Signal-Regulatory Protein-α (SIRP- α) Expression Delineates Distinct Subsets in Monocytes/Macrophages in Normal Tissue and in B-Cell Non-Hodgkin Lymphoma

Ya-Ping Chen, MD, PhD, Zhi-Zhang Yang, MD, Jose C. Villasboas, MD, Tammy Price-Troska, BS, Hyo Jin Kim, PhD, Anne J. Novak, PhD, Stephen M Ansell, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 2515.
https://doi.org/10.1182/blood.V128.22.2515.2515
Published: 2016
Journal Articles

Telomerase Inhibition with Imetelstat Eradicates β-Catenin Activated Blast Crisis Chronic Myeloid Leukemia Stem Cells

Wenxue Ma, MD, PhD, Cayla N Mason, BS, Ping Chen, MD PhD, Nathaniel Delos Santos, BS, Jiang Qingfei, PhD, Elisa Lazzari, PhD, Fei Huang, Larisa Balaian, PhD, Catriona H.M. Jamieson, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3065.
https://doi.org/10.1182/blood.V128.22.3065.3065
Published: 2016
Journal Articles

Pegylated Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory and/or Elder Acute Myeloid Leukemia: The Preliminary Result of Phase II Trial

Hui-Jen Tsai, MD PhD, Ming-Chung Wang, MD, Sheng-Fung Lin, MD, Ya-Ping Chen, MD PhD, Hui-Hwa Hsiao, MD PhD, Ching-Yuan Kuo, MD, Li-Tzong Chen, MD PhD, Tsai-Yun Chen, MD
Journal: Blood
Blood (2014) 124 (21): 984.
https://doi.org/10.1182/blood.V124.21.984.984
Published: 2014